Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/16/11 | Quarterly report pursuant to Section 13 or 15(d) |
|
58 | ||
| 05/12/11 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/12/11 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/12/11 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 05/12/11 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 05/12/11 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/12/11 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/12/11 | Statement of changes in beneficial ownership of securities |
|
3 | ||
| 04/22/11 | Current report filing |
|
2 | ||
| 04/19/11 | Statement of changes in beneficial ownership of securities |
|
2 |